# Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component

> **NCT03681639** · NA · COMPLETED · sponsor: **Zimmer Biomet** · enrollment: 45 (actual)

## Conditions studied

- Avascular Necrosis of Hip
- Osteoarthritis, Hip
- Rheumatoid Arthritis
- Inflammatory Arthritis
- Post-traumatic; Arthrosis

## Interventions

- **DIAGNOSTIC_TEST:** Serum Metal ion levels determined to monitor changes in chromium and cobalt levels

## Key facts

- **NCT ID:** NCT03681639
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-01
- **Primary completion:** 2023-05-22
- **Final completion:** 2023-05-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681639, "Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT03681639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*